Phase 1b/II study of buparlisib with chemo in squamous NSCLC patients
Research type
Research Study
Full title
A dose-finding phase Ib study followed by a randomized,double-blind phase II study of carboplatin and paclitaxel with or without buparlisib in patients with previously untreated metastatic non-small cell lung cancer (NSCLC) of squamous histology
IRAS ID
134208
Contact name
Samreen Ahmed
Contact email
Sponsor organisation
Novartis Pharma Services AG
Eudract number
2012-005541-21
ISRCTN Number
n/a
Clinicaltrials.gov Identifier
n/a
REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
13/WM/0301
Date of REC Opinion
28 Aug 2013
REC opinion
Favourable Opinion